These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27638657)

  • 1. A Survey of Adverse Event Reporting Practices Among US Healthcare Professionals.
    Stergiopoulos S; Brown CA; Felix T; Grampp G; Getz KA
    Drug Saf; 2016 Nov; 39(11):1117-1127. PubMed ID: 27638657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Texas pharmacists' opinions on reporting serious adverse drug events to the Food and Drug Administration: a qualitative study.
    Gavaza P; Brown CM; Khoza S
    Pharm World Sci; 2010 Oct; 32(5):651-7. PubMed ID: 20652830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Res Social Adm Pharm; 2011 Dec; 7(4):369-82. PubMed ID: 21272531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sharing Adverse Drug Event Reports Between Hospitals and Community Pharmacists to Inform Re-dispensing: An Analysis of Reports and Process Outcomes.
    Cragg A; Small SS; Lau E; Rowe A; Lau A; Butcher K; Hohl CM
    Drug Saf; 2023 Nov; 46(11):1161-1172. PubMed ID: 37783974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    Br J Clin Pharmacol; 2011 Jul; 72(1):143-52. PubMed ID: 21332572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of social influences on pharmacists' intention to report adverse drug events.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
    J Am Pharm Assoc (2003); 2012; 52(5):622-9. PubMed ID: 23023842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An examination of adverse drug event monitoring practices in U.S. hospitals.
    Juergens JP; Szeinbach SL
    Top Hosp Pharm Manage; 1992 Jul; 12(2):1-11. PubMed ID: 10128724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Texas pharmacists' knowledge of reporting serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Wilson JP; Steinhardt M
    J Am Pharm Assoc (2003); 2011; 51(3):397-403. PubMed ID: 21555292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist reporting of serious adverse drug events to the Food and Drug Administration.
    Gavaza P; Brown CM; Lawson KA; Rascati KL; Steinhardt M; Wilson JP
    J Am Pharm Assoc (2003); 2012; 52(5):e109-12. PubMed ID: 23023857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceived barriers to reporting adverse drug events in hospitals: a qualitative study using theoretical domains framework approach.
    Mirbaha F; Shalviri G; Yazdizadeh B; Gholami K; Majdzadeh R
    Implement Sci; 2015 Aug; 10():110. PubMed ID: 26250159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse drug reaction reporting by general medical practitioners and retail pharmacists in Harare--a pilot study.
    Ball D; Tisócki T
    Cent Afr J Med; 1998 Aug; 44(8):190-5. PubMed ID: 10101417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of physicians' attitudes on reporting adverse drug events: a case-control study.
    Figueiras A; Tato F; Fontaiñas J; Gestal-Otero JJ
    Med Care; 1999 Aug; 37(8):809-14. PubMed ID: 10448723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot testing of checklists to discern adverse drug reactions and adverse drug events.
    Chen AM; Kiersma ME; Shepler BM; Murawski MM
    J Am Pharm Assoc (2003); 2013; 53(1):61-9. PubMed ID: 23636158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia.
    Alshammari TM; Alamri KK; Ghawa YA; Alohali NF; Abualkol SA; Aljadhey HS
    Int J Clin Pharm; 2015 Dec; 37(6):1104-10. PubMed ID: 26216270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy students' attitudes toward reporting serious adverse drug events.
    Gavaza P; Bui B
    Am J Pharm Educ; 2012 Dec; 76(10):194. PubMed ID: 23275659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.
    Dorji C; Tragulpiankit P; Riewpaiboon A; Tobgay T
    Drug Saf; 2016 Dec; 39(12):1239-1250. PubMed ID: 27743333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medication safety knowledge, attitudes and practices among community pharmacists in Lebanon.
    Hajj A; Hallit S; Ramia E; Salameh P;
    Curr Med Res Opin; 2018 Jan; 34(1):149-156. PubMed ID: 28758813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug event reporting in intensive care units: a survey of current practices.
    Kane-Gill SL; Devlin JW
    Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing an Adverse Drug Event Reporting System to Prevent Unintentional Reexposures to Harmful Drugs: Study Protocol for a Multiple Methods Design.
    Peddie D; Small SS; Badke K; Wickham ME; Bailey C; Chruscicki A; Ackerley C; Balka E; Hohl CM
    JMIR Res Protoc; 2016 Aug; 5(3):e169. PubMed ID: 27538362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse drug reactions reporting: pharmacists' knowledge, attitude and practice in Shiraz, Iran.
    Afifi S; Maharloui N; Peymani P; Namazi S; Gharaei AG; Jahani P; Lankarani KB
    Int J Risk Saf Med; 2014; 26(3):139-45. PubMed ID: 25214159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.